MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WILL, P. C.
Right arrow Articles by NOTEBOOM, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WILL, P. C.
Right arrow Articles by NOTEBOOM, W. D.

Molecular Pharmacology, Vol 14, 856-867, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

Methadone Uptake by L5178Y Mouse Leukemic Cells

PETER C. WILL 1 and WILLIAM D. NOTEBOOM 1

1 Department of Biochemistry, University of Missouri, Columbia, Missouri 65201

Mouse leukemic cells accumulate methadone at 37° while at 0° drug associated with the cells is constant. After a suitable incubation period the accumulation at 37° ceases and the net drug associated with the cells remains constant. This steady-state level (37° uptake minus 0° uptake) increases in proportion to the free drug concentration up to at least 0.7 mM methadone where the cells contain 2.5 fmol/cell. The cells apparently concentrate methadone at 7.5-16 times the medium concentration. The rate of uptake appears to be a complex function of the free methadone concentration in the medium, however, no definite saturation was observed. The loss of [3H]methadone from cells preloaded with drug is very rapid and the extent of loss is independent of the concentration of methadone in the medium. Methadone appears to be only weakly bound by the cells and is readily accessible to the medium. Various metabolic inhibitors do not reduce methadone uptake; further, the results of competition experiments with other opiates and the stereoisomers of methadone reveal little, if any, uptake specificity for methadone. We conclude that methadone is accumulated by passive diffusion which may involve extensive intracellular binding of the drug by macromolecules and/or partitioning of the drug into hydrophobic regions of the cell.

Submitted on May 12, 1978
Accepted on May 26, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics